Abstracts
2021 - Oral communication
OA-Genetics and EUROGOUT-InflammationCD11B DEFICIENCY PROMOTES INFLAMMASOME ACTIVATION IN MACROPHAGES AND AGGRAVATES MSU-INDUCED JOINT INFLAMMATION IN MICE
Driss Ehirchiou, Ilaria Bernabei, Veronique Chobaz, Sonia Nasi, Mariela Castelblanco , Alexander So , Hans Acha-Orbea, Thomas Hugle, Li Zhang, Nathalie Busso
2021 - Oral communication
OA-Genetics and EUROGOUT-InflammationTRANSLATING THE MULTI-TRAIT REGULATORY LANDSCAPE AT SLC2A9
Megan Leask, James Boocock, Hyon Choi, Tayaza Fadason, Justin O’Sullivan, Lisa Stamp, Nicola Dalbeth, Julia Horsfield, Tony R Merriman
2021 - Oral communication
Therapeutics-MiscellaneousMICROGLIA CONTROL SMALL VESSEL CALCIFICATION VIA TREM2
Yvette Zarb(1) , Sina Nassiri(2), Sebastian Guido Utz(3), Johanna Schaffenrath(1), Mauro Delorenzi(2), Marco Colonna(4), Melanie Greter(3), Annika Keller(1)
2021 - Oral communication
Mechanisms-EpidemiologyTHE INFLAMMATORY ROLE OF THE SILENT URATE CRYSTAL DEPOSITION IN INTERCRITICAL GOUT
Cesar Diaz-Torne (1), Maria A. Ortiz (2), Sicylle Jeria-Navarro (1), Andrea Garcia-Guillem (1), Lluis Sanz (1), Susana Hernandez (1), Silvia Vidal (2)
2021 - Oral communication
Therapeutics-MiscellaneousA precise identification of crystal deposits in the kidney tissue
Frochot V, Jouanneau C, Letavernier E, Haymann JPh, Bazin D, Daudon M.
2021 - Oral communication
OA-Genetics and EUROGOUT-InflammationDOES EXCESS WEIGHT AFFECT GOUT RISK DIFFERENTLY AMONG GENETICALLY PREDISPOSED INDIVIDUALS? – SEX-SPECIFIC PROSPECTIVE COHORT FINDINGS OVER >26 YEARS
Chio Yokose, Md1,2; Natalie Mccormick, Phd1,2,3; Na Lu, Mph3,4; Amit D. Joshi, Mbbs, Phd5; Hyon K. Choi, Md, Drph1,2,3,4
2021 - Oral communication
Therapeutics-MiscellaneousPSEUDOXANTHOMA ELASTICUM (PXE) PATIENTS AND HETEROZYGOUS CARRIERS HAVE DECREASED PLASMA PPI LEVELS WHICH CORRELATE WITH THE CARDIO(VASCULAR) PHENOTYPE.
M. Van Gils [1,2], J. Depauw [1], S. Verschuere [1,2], L. Nollet [1,2], O.M. Vanakker [1,2]
2021 - Oral communication
Mechanisms of CalcificationTHE GASOTRANSMITTER HYDROGEN SULFIDE (H2S) IS PROTECTIVE AGAINST CALCIFIC TENDINOPATHY (CT)
Bernabei I.1, Kronenberg D.2, Stange R.2, Bertrand J.3, Hügle T1., So A.1, Busso N.1, Nasi S.1
2021 - Oral communication
Mechanisms-EpidemiologyIS REPEAT SERUM URATE TESTING SUPERIOR TO A SINGLE TEST TO PREDICT INCIDENT GOUT OVER TIME?
Sarah Stewart, Amanda Phipps-Green, Greg D. Gamble, Lisa K. Stamp, William J. Taylor, Tuhina Neogi, Tony R. Merriman, Nicola Dalbeth
2021 - Oral communication
Therapeutics-MiscellaneousEFFECT OF LEFLUNOMIDE ON PEGLOTICASE RESPONSE RATE IN PATIENTS WITH UNCONTROLLED GOUT
Karim Richard Masri [1], Kevin Winterling [2], Brian Lamoreaux [2]
2021 - Oral communication
Therapeutics-MiscellaneousTARGETING DYSFUNCTIONAL DNA DAMAGE RESPONSE AND PARP1 SIGNALING REDUCES ECTOPIC CALCIFICATION IN PSEUDOXANTHOMA ELASTICUM
Lukas Nollet, Matthias Van Gils, Olivier M. Vanakker
2021 - Oral communication
Mechanisms of CalcificationACTIVE SCREENING FOR GOUT IDENTIFIES A LARGER CARDIOVASCULAR POPULATION AT HIGH MORTALITY RISK.
Silvia Ruiz-Simón, Medical Student; Irene Calabuig, Md; Miguel Gómez-Garberí, Md; Mariano Andrés, Md, Phd.
2021 - Oral communication
Medication taking behavior of allopurinol treatment among patients with gout: a retrospective cohort study in the clinical practice research datalink (CPRD)
Scheepers L.E.J.M. 1, Burden A. M. 2, Spaetgens B.1, 2 , Arts I.C.W. 3, de Vries F. 2, A. Boonen A. 1
2021 - Oral communication
Failure to reach serum urate target is associated with elevated mortality in gout
F. Pérez-Ruiz 1, P. Richette 2, A. G. Stack 3, R. Karra Gurunath 4, M. J. García De Yebenes 5, L. Carmona 5
2021 - Oral communication
Therapeutics-MiscellaneousEFFECT OF METFORMIN ON CLINICAL GOUT OUTCOMES IN GOUT PATIENTS WITH DIABETES MELLITUS
F. Veenstra 1, Lm. Verhoef 1, M. Opdam 1, Aa. Den Broeder 1,3, W. Kwok 2, I. Meek 3, Fhj. Van Den Hoogen 1,3, M. Flendrie 1, N. Van Herwaarden 1,3
2021 - Oral communication
OA-Genetics and EUROGOUT-InflammationRECENT FINDINGS IN CLINICO-GENETICS ANALYSES FOR CLINICALLY-DEFINED GOUT
Hirotaka Matsuo 1), Masahiro Nakatochi 2), Akiyoshi Nakayama 1), Yusuke Kawamura 1), Yu Toyoda 1), Seiko Shimizu 1), Tappei Takada 3), Kimiyoshi Ichida 4), Nariyoshi Shinomiya 1), Yukinori Okada 5)
2021 - Oral communication
Therapeutics-MiscellaneousOUTCOMES OF CARE AMONG PATIENTS WITH GOUT IN EUROPE: A CROSS-SECTIONAL SURVEY
Ritch Te Kampe(1,2), Tim L. Jansen(2), Caroline Van Durme(1), Matthijs Janssen(2), Gudula Petersen(3), Annelies Boonen(1)
2021 - Oral communication
Therapeutics-MiscellaneousIS IT WORTH A TRY? APPLYING ECONOMIC EVALUATION TO COMPARE FEBUXOSTAT WITH THE RISK OF ALLOPURINOL INDUCED SJS-TEN
J. Hwang 1, S. K. Cho 2,3